Skip to content
- 10/06/2017: A research paper titled, Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor-Modified T Cells Engineered to Secrete Checkpoint Inhibitors, is accepted for publication in Clinical Cancer Research. Congratulation to Si Li, Ploy Siriwon and other coauthors from the Wang lab!
- 09/20/2017: A research paper titled, Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers, is accepted for publication in Molecular Therapy. Congratulation to Elizabeth Siegler and other coauthors from the Wang lab!
- 09/10/2017: A research paper titled, Breast Cancer Vaccines Delivered by Dendritic Cell-Targeted Lentivectors Induce Potent Antitumor Immune Responses and Protect Mice from Mammary Tumor Growth, is accepted for publication in Vaccine. Congratulation to Paul Bryson and other coauthors from the Wang lab!
- 09/01/2017: A research paper titled, Designed Ankyrin Repeat Proteins as Her2 Targeting Domains in Chimeric Antigen Receptor-Engineered T Cells, is accepted for publication in Human Gene Therapy. Congratulation to Elizabeth Siegler and other coauthors from the Wang lab!
- 07/21/2017: A research paper titled, Dendritic Cell-Targeted Lentiviral Vector Immunization Uses Pseudotransduction and DNA-Mediated STING and cGAS Activation, is accepted for publication in Science Immunology. Congratulation to Jocelyn Kim and other coauthors from the Wang lab!
- 07/20/2017: A research paper titled, Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering, is accepted for publication in Molecular Therapy. Congratulation to Xiaolu Han and other coauthors from the Wang lab!
- 01/04/2017: A research paper titled, Masked Chimeric Antigen Receptor for Tumor-Specific Activation, is accepted for publication in Molecular Therapy. Congratulation to Xiaolu Han and other coauthors from the Wang lab!